The effect of Ezetimibe in hypercholesterolemic patients with Nonaicoholic fatty liver disease(NAFLD)
Not Applicable
- Conditions
- onaicoholic fatty liver disease
- Registration Number
- JPRN-UMIN000002440
- Lead Sponsor
- Saiseikai Suita Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.patients being taken Ezetimibe 2.patients with serious liver disease 3.secondary hyperlipidemia or drug-induced hyperlipidemia 4.pregnant or lactating women 5.aicoholconsumption>21g/day
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Histological and immunohistochemical analysis of analysis of liver 2) L/S ratio by CT 3) Various biological markers of liver didease.
- Secondary Outcome Measures
Name Time Method